The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia-Reference-Cited by-同舟云学术

The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia

Published:2019-09-13 Issue:1 Volume:25 Page:203-209
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Sato Shizuka,Yamamoto Eiko^ORCID,Niimi Kaoru,Ino Kazuhiko,Nishino Kimihiro,Suzuki Shiro,Kotani Tomomi,Kajiyama Hiroaki,Kikkawa Fumitaka

Funder

JSPS KAKENHI Grant

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-019-01540-9.pdf

Reference24 articles.

1. Lybol C, Thomas CM, Blanken EA et al (2013) Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia. Eur J Cancer 49(4):860–867. https://doi.org/10.1016/j.ejca.2012.09.015

2. Lu WG, Ye F, Shen YM et al (2008) EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: a clinical analysis of 54 patients. Int J Gynecol Cancer 18(2):357–362. https://doi.org/10.1111/j.1525-1438.2007.00999.x

3. Bower M, Newlands ES, Holden L et al (1997) EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol 15(7):2636–2643. https://doi.org/10.1200/JCO.1997.15.7.2636

4. Kim SJ, Bae SN, Kim JH et al (1998) Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen. Gynecol Oncol 71(2):247–253. https://doi.org/10.1006/gyno.1998.5161

5. Escobar PF, Lurain JR, Singh DK et al (2003) Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy. Gynecol Oncol 91(3):552–557

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of transport mechanisms of methotrexate in human choriocarcinoma cell lines by LC-MS/MS;Journal of Pharmaceutical and Biomedical Analysis;2024-09

2. Evolution of Treatment Strategies for Gestational Trophoblastic Neoplasia: Chemotherapy, Immunotherapy, and Molecular Targeted Therapy;Current Treatment Options in Oncology;2024-07-25

3. Maximizing ovarian function and fertility following chemotherapy in premenopausal patients: Is there a role for ovarian suppression?;Gynecologic Oncology Reports;2024-06

4. Nobiletin alleviates methotrexate-induced hepatorenal toxicity in rats;Biotechnic & Histochemistry;2024-04-02

5. Increase in the level of β-HCG after uterine artery embolization in the context of partial molar pregnancy: A case report;Case Reports in Women's Health;2023-09